| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.04 | 0.8 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |